TekniPlex Healthcare will give a presentation exploring materials science progress that aids the administration of critical liquids and other medical fluids at AMI’s Medical Tubing & Catheters Conference, 1-2 November in Tampa, FL.
On 1st November at 9:50am, two TekniPlex Healthcare experts – Alex Kakad, global product manager, and Gary Mizenko, global head of technical operations – will present New Tubing Advancements Drive Dramatic Improvements for Critical Fluid Transfer Applications.
Among other points of interest, those attending the lecture will learn about tubing solutions for peristaltic pump applications that offer multiple, marked improvements over their conventional, silicone-based counterparts. Kakad and Mizenko will explore the causes of several common failures, and discuss recent design improvements for multilayer tubing used, for example, with infusion systems. The duo will provide real-world examples of problem solving across several tubing scenarios, and also cover validation techniques to best ensure consistent dimensional and peel strength tolerancing for fluid management solutions.
TekniPlex Healthcare is a specialist in medical tubing applications, including paratubing solutions produced in up to eight custom-coloured, textured or striped tube formations to distinguish between flow paths. The company’s validated manufacturing processes yield paratubes with uniform, repeatable and consistent bonding strength between 0.22 and 1.5 pounds, protecting dimensional stability and ensuring each individual tubing line’s integrity. Maintaining consistent bonding strength prevents individual tubes from separating prematurely and being rejected by healthcare providers, and also eliminates the need for excessive force to peel the tubes apart, which can damage or distort them to the detriment of patients.
TekniPlex Healthcare is also dedicated to developing custom solutions to unique problems in the medical and bioprocess fields. Recent examples include patented multilayer tubing configurations that offer extremely low absorption properties to help extend the usable life of insulin and other unstable drug products, such as chemotherapy drugs. Another patented configuration, designed for fluid transfer of DMSO and other solvent suspensions, allows for safe product delivery in dual hormone delivery systems and advanced cell & gene therapy processes.